Education
About Us
Working with TipRanks
Follow Us
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
Xeris Pharmaceuticals (XERS) Ownership Overview
5.99% Insiders
8.08% Mutual Funds
9.74% Other Institutional Investors
11.34% ETFs
64.86% Public Companies and Individual Investors
The ownership structure of Xeris Pharmaceuticals (XERS) stock is a mix of institutional, retail, and individual investors. Approximately 29.15% of the company’s stock is owned by Institutional Investors, 5.99% is owned by Insiders, and 64.86% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 16, 2025 | xxxxxxxxxxxxx | $109250 | |
Mar 21, 2025 | xxxxxxxxxxxxx | $217200 | |
Aug 13, 2024 | xxxxxxxxxxxxx | $10114 | |
Aug 12, 2024 | xxxxxxxxxxxxx | $10113 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $415625 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $733837 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $7749354 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,835,339 | Institution | 4.89% | 34,083,725 | |
| 6,580,350 | Institution | 4.11% | 28,624,523 | |
| 5,426,343 | Institution | 3.39% | 23,604,592 | |
| 2,687,118 | Insider | 1.68% | 11,688,963 | |
| 2,659,248 | Institution | 1.66% | 11,567,729 | |
| 1,710,585 | Insider | 1.07% | 7,441,045 | |
| 1,520,559 | Institution | 0.95% | 6,614,432 | |
| 1,458,943 | Institution | 0.91% | 6,346,402 | |
| 1,417,561 | Insider | 0.89% | 6,166,390 | |
| 1,411,540 | Institution | 0.88% | 6,140,199 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,580,350 | Institution | 4.11% | 28,624,523 | |
| 1,520,559 | Institution | 0.95% | 6,614,432 | |
| 1,458,943 | Institution | 0.91% | 6,346,402 | |
| 782,555 | Institution | 0.49% | 3,404,114 | |
| 689,764 | Institution | 0.43% | 3,000,473 | |
| 402,872 | Institution | 0.25% | 1,752,493 | |
| 250,011 | Institution | 0.16% | 1,087,548 | |
| 152,257 | Institution | 0.10% | 662,318 | |
| 144,000 | Institution | 0.09% | 626,400 | |
| 142,462 | Institution | 0.09% | 619,710 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,223,757 | Institution | 2.64% | 19,302,569 | |
| 3,527,557 | Institution | 2.20% | 15,344,873 | |
| 2,363,909 | Institution | 1.48% | 10,803,064 | |
| 1,199,582 | Institution | 0.75% | 5,218,182 | |
| 702,791 | Institution | 0.44% | 3,211,755 | |
| 641,300 | Institution | 0.40% | 2,834,546 | |
| 641,300 | Institution | 0.40% | 2,834,546 | |
| 641,300 | Institution | 0.40% | 2,834,546 | |
| 456,386 | Institution | 0.28% | 1,985,279 | |
| 452,437 | Institution | 0.28% | 1,968,101 |
FAQ
Who Owns Xeris Pharmaceuticals (XERS)?
According to the latest TipRanks data, approximately 9.74% of the company's stock is held by institutional investors, 5.99% is held by insiders, and 64.86% is held by retail investors.
What percentage of Xeris Pharmaceuticals (XERS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.74% of Xeris Pharmaceuticals (XERS) stock is held by institutional investors.
What percentage of Xeris Pharmaceuticals (XERS) stock is held by retail investors?
According to the latest TipRanks data, approximately 64.86% of Xeris Pharmaceuticals (XERS) stock is held by retail investors.
Who owns the most shares of Xeris Pharmaceuticals (XERS)?
Vanguard owns the most shares of Xeris Pharmaceuticals (XERS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.